Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 5Phase 3 3Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 43Carcinoma, Neuroendocrine 8Gastro-enteropancreatic neuroendocrine tumor 7Sarcoma 6Carcinoid Tumor 6Stomach Neoplasms 5Small Cell Lung Carcinoma 5Paraganglioma 5Neoplasms 5Prostatic Neoplasms 4Pheochromocytoma 4Neoplasm Metastasis 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 4Thyroid Neoplasms 3Neuroblastoma 3Carcinoma, Renal Cell 3Thyroid Diseases 2Thoracic Neoplasms 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Ovarian Neoplasms 2Neuroectodermal Tumors 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Site 2Neoplasms by Histologic Type 2Meningioma 2Medulloblastoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Adenoma, Islet Cell × NET × Clear all
NCT02038738 2014-01-17

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Ochsner Health System

Phase 1/2 Unknown
250 enrolled
EndocrineNET

Apudoma, Carcinoid Tumor, Adenoma, Islet Cell, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡